Gene induction by glycyrol to apoptosis through endonuclease G in tumor cells and prediction of oncogene function by

SungGa Lee1, Hyun-Mee Oh, Won-Bong Lim

  • 1Department of Oral Pathology, 2nd Stage of Brain Korea 21 for School of Dentistry, Dental Science Research Institute, Korea.

Anti-Cancer Drugs
|April 18, 2008
PubMed

Insights

Glycyrrhiza uralensis flavonoid glycyrol (GC) inhibits inflammatory gene expression by blocking nuclear factor-kappaB (NF-κB) activation. GC also promotes apoptosis in kidney cells, suggesting potential anti-cancer properties.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Immunology

Background:

  • Glycyrrhiza uralensis possesses known anti-inflammatory properties.
  • The flavonoid glycyrol (GC) is isolated from G. uralensis.
  • Nuclear factor-kappaB (NF-κB) is a key regulator of inflammatory responses.

Purpose of the Study:

  • To investigate the effect of glycyrol (GC) on global gene expression.
  • To elucidate the mechanism by which GC modulates NF-κB activity.
  • To explore GC's role in apoptosis pathways.

Main Methods:

  • High-density oligonucleotide microarrays for gene expression profiling.
  • Luciferase reporter assays to measure NF-κB transcriptional activity.
  • Reverse transcription-polymerase chain reaction (RT-PCR) for gene validation.
  • Western blot analysis to assess I-κB degradation.

Main Results:

  • GC significantly inhibited phorbol ester-induced NF-κB-dependent transcriptional activity.
  • Microarray analysis revealed downregulation of inflammatory genes (e.g., CCL2, CCL7, CD44, HSPB8) by GC.
  • GC treatment inhibited I-κB degradation, a key step in NF-κB activation.
  • GC induced p53-dependent apoptosis via endonuclease G in human kidney cells.

Conclusions:

  • Glycyrol (GC) effectively suppresses inflammatory gene expression by inhibiting NF-κB activation.
  • GC demonstrates a pro-apoptotic effect in human kidney cells, potentially through endonuclease G.
  • These findings highlight the therapeutic potential of GC in inflammatory diseases and cancer.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...